Prior research has observed increased expression levels of PRDX1 in numerous cancer types, including non‐small cell lung cancer (NSCLC), ovarian cancer (OC), prostate cancer, colorectal cancer, and gastric cancer [49, 50, 51, 52]. Here, PRDX1 is linked to prostate carcinoma.